Gut microbiota in patients with Parkinson's disease in southern China

Parkinsonism and Related Disorders

Volumn 53, Issue , 2018, Pages 82-88

  Lin, Aiqun ^a   Zheng, Wenxia ^a   He, Yan ^a   Tang, Wenli ^a   Wei, Xiaobo ^a   He, Rongni ^a   Huang, Wei ^a   Su, Yuying ^a   Huang, Yaowei ^b   Zhou, Hongwei ^a,b   Xie, Huifang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

16S rRNA next generation sequencing; Clinical motor phenotype; Gut microbiota; Parkinson's disease

Indexed keywords

RNA 16S;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BIFIDOBACTERIACEAE; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; FECES MICROFLORA; FEMALE; HUMAN; INTESTINE FLORA; LACHNOSPIRACEAE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEXT GENERATION SEQUENCING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SPECIES COMPOSITION; AGED; HIGH THROUGHPUT SEQUENCING; MICROBIOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SEQUENCE ANALYSIS;

AGED; CHINA; FEMALE; GASTROINTESTINAL MICROBIOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA;

EID: 85046860275     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2018.05.007     Document Type: Article

References (31)

1. Mukherjee, A., Biswas, A., Das, S.K., Gut dysfunction in Parkinson's disease. World J. Gastroenterol., 22, 2016, 5742.
2. Fang, X., Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis. Int. J. Neurosci. 126:9 (2015), 771–776.
3. Keshavarzian, A., Green, S.J., Engen, P.A., Voigt, R.M., Naqib, A., Forsyth, C.B., et al. Colonic bacterial composition in Parkinson's disease. Mov. Disord. 30 (2015), 1351–1360.
4. Parashar, A., Udayabanu, M., Gut microbiota: implications in Parkinson's disease. Park. Relat. Disord. 38 (2017), 1–7.
5. Derkinderen, P., Rouaud, T., Lebouvier, T., Bruley, D.V.S., Neunlist, M., De Giorgio, R., Parkinson disease: the enteric nervous system spills its guts. Neurology 77 (2011), 1761–1767.
6. Pereira, P., Aho, V., Paulin, L., Pekkonen, E., Auvinen, P., Scheperjans, F., Oral and nasal microbiota in Parkinson's disease. Park. Relat. Disord. 38 (2017), 61–67.
7. Klingelhoefer, L., Reichmann, H., The gut and nonmotor symptoms in Parkinson's disease. Int. Rev. Neurobiol. 134 (2017), 787–809.
8. Cersosimo, M.G., Raina, G.B., Pecci, C., Pellene, A., Calandra, C.R., Gutierrez, C., et al. Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms. J. Neurol. 260 (2013), 1332–1338.
9. Tan, A.H., Mahadeva, S., Thalha, A.M., Gibson, P.R., Kiew, C.K., Yeat, C.M., et al. Small intestinal bacterial overgrowth in Parkinson's disease. Park. Relat. Disord. 20 (2014), 535–540.
10. Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., et al. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features. Sci. China Life Sci. 60 (2017), 1869–1889.
11. Fasano, A., Visanji, N.P., Liu, L.W., Lang, A.E., Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 14 (2015), 625–639.
12. Bedarf, J.R., Hildebrand, F., Coelho, L.P., Sunagawa, S., Bahram, M., Goeser, F., et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. Genome Med., 9(1), 2017, 39.
13. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
14. Pistollato, F., Sumalla, C.S., Elio, I., Masias, V.M., Giampieri, F., Battino, M., Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74 (2016), 624–634.
15. Arora, T., Backhed, F., The gut microbiota and metabolic disease: current understanding and future perspectives. J. Intern. Med. 280 (2016), 339–349.
16. Forsyth, C.B., Shannon, K.M., Kordower, J.H., Voigt, R.M., Shaikh, M., Jaglin, J.A., et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One, 6, 2011 e28032.
17. Kelly, L.P., Carvey, P.M., Keshavarzian, A., Shannon, K.M., Shaikh, M., Bakay, R.A., et al. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov. Disord. 29 (2014), 999–1009.
18. Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167 (2016), 1469–1480.
19. Burns, E.H., Debelius, J.W., Morton, J.T., Wissemann, W.T., Lewis, M.R., Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov. Disord. 32:5 (2017), 739–749.
20. Unger, M.M., Spiegel, J., Dillmann, K., Grundmann, D., Philippeit, H., Bürmann, J., et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Park. Relat. Disord. 32 (2016), 66–72.
21. Hopfner, F., Künstner, A., Müller, S.H., Künzel, S., Zeuner, K.E., Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 1677 (2017), 41–45.
22. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., et al. Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
23. Muangpaisan, W., Hori, H., Brayne, C., Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J. Epidemiol. 19 (2009), 281–293.
24. Ma, C.L., Su, L., Xie, J.J., Long, J.X., Wu, P., Gu, L., The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis. J. Neural. Transm. 121 (2014), 123–134.
25. Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 30:3 (2015), 350–358.
26. Duncan, S.H., Barcenilla, A., Stewart, C.S., Pryde, S.E., Flint, H.J., Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl. Environ. Microbiol. 68 (2002), 5186–5190.
27. Barcenilla, A., Pryde, S.E., Martin, J.C., Duncan, S.H., Stewart, C.S., Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66:4 (2000), 1654–1661.
28. Petrov, V.A., Saltykova, I.V., Zhukova, I.A., Alifirova, V.M., Zhukova, N.G., Dorofeeva, Y.B., et al. Analysis of gut microbiota in patients with Parkinson's disease. Bull. Exp. Biol. Med. 162 (2017), 734–737.
29. Ferguson, L.W., Rajput, A.H., Rajput, A., Early-onset vs. Late-onset Parkinson's disease: a clinical-pathological study. Can. J. Neurol. Sci. 43 (2016), 113–119.
30. Wickremaratchi, M.M., Knipe, M., Sastry, B., Morgan, E., Jones, A., The motor phenotype of Parkinson's disease in relation to age at onset. Mov. Disord. 26:3 (2011), 457–463.
31. Park, C.H., Han, D.S., Oh, Y.H., Lee, A.R., Lee, Y.R., Eun, C.S., Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis. Sci. Rep., 6, 2016, 25271.